慢性阻塞性肺疾病合并呼吸衰竭临床剖析.docVIP

慢性阻塞性肺疾病合并呼吸衰竭临床剖析 　　[摘要]目的 分析慢性阻塞性肺疾病合并呼吸衰竭在临床上的治疗效果。 方法 选取我院2010年1月～2012年12月收治的80例慢性阻塞性肺疾病合并呼吸衰竭患者的临床资料，分为治疗组和对照组，在标准治疗基础上治疗组40例采用雾化吸入莫西沙星溶液治疗，对照组40例采用雾化吸入沙丁胺醇治疗。 结果 治疗组患者治疗后的用力肺活（FVC），1 s用力呼气量（FEV）和最大呼气流速（PEF）水平均明显高于对照组；治疗组的治疗情况比观察组的治疗情况要显著提高，治疗组的治愈率为32.50%、有效率为50.00%、无效率为17.50%、总有效率为82.50%，对照组的治愈率为27.50%、有效率为42.50%、无效率为30.00%、总有效率为70.00%，治疗组的总有效率明显高于对照组。 结论 莫西沙星在改善慢性阻塞性肺病合并呼吸衰竭患者病情方面具有显著作用。 　　[关键词]慢性阻塞性肺疾病；呼吸衰竭 　　[中图分类号] R563.9；563.8 [文献标识码] B [文章编号] 2095-0616（2013）13-177-02 　　Clinical analysis on the treatment of chronic obstructive pulmonary disease combined with respiratory failure 　　JIANG Chuanjie 　　Department of Internal Medicine，Daoqing Hospital of Tonghua Mining Group，Baishan 134309，China 　　[Abstract] Objective To analyze the clinical effect of chronic obstructive pulmonary disease with respiratory failure in clinical diagnosis and the therapeutic effect analysis. Methods The clinical data of 80 cases of patients with chronic obstructive pulmonary disease and respiratory failure in our hospital during the period of January 2010 to December 2012 were objected and studied，and the clinical diagnosis and treatment were reviewed.All patientswere divided into treatment group and control group，on the basis of conventional therapy，the treatment group of 40 cases were given inhalation of moxifloxacin solution treatment，the control group of 40 patients were given salbutamol atomization inhalation. Results The patients in the treatment group after treatment （FVC），forced lung biopsy 1 s forced expiratory volume （FEV） and peak expiratory flow （PEF） levels were significantly higher than those in the control group；treatment group was higher than that of treatment to the observation group，the cure rate in treatment group was 32.50%，efficiency of 50%，no efficiency was 17.50%，the total effective rate was 82.50%.In the control group，the cure rate was 27.50%，effective rate was 42.50%，no efficiency was 30.00%，the total effective rate was 70.00%，the total effective rat